Cancer - Could it be cured? A spontaneous regression of cancer, cancer energy metabolism, hyperglycemia-hypoglycemia, Metformin, Warburg and Crabtree effects and a new perspective in cancer treatment

Journal of Cancer Science and Therapy

Volumn 6, Issue 3, 2014, Pages 56-61

  Oleksyszyn, Jozef ^a   Wietrzyk, Joanna ^b   Psurski, Mateusz ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cancer cells; Cancer energy metabolism; Cancer metabolism; Cancer treatment; Malignant tumor; Tumor regression

Indexed keywords

GLUTATHIONE; METFORMIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE; UNCOUPLING PROTEIN 2;

APOPTOSIS; CANCER THERAPY; ENERGY METABOLISM; GENE MUTATION; GLYCOLYSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NEOPLASM; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; REVIEW;

EID: 84898874656     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000249     Document Type: Review

References (69)

1. Challis GB, Stam HJ (1990) The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol 29: 545-550.
2. Chodorowski Z, Anand JS, Wiśniewski M, Madaliński M, Wierzba K, et al. (2007) [Spontaneous regression of cancer--review of cases from 1988 to 2006]. Przegl Lek 64: 380-382.
3. Karbach J, Neumann A, Brand K, Wahle C, Siegel E, et al. (2012) Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Cli Cancer Res 18: 5449-5459.
4. Jessy T (2011) Immunity over inability: The spontaneous regression of cancer. J Nat Sci Biol Med 2: 43-49.
5. Zahl PH, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168: 2311-2316.
6. Gladwish A, Clarke K, Bezjak A (2010) Spontaneous regression in advanced non-small cell lung cancer. BMJ Case Rep 2010.
7. Bir AS, Fora AA, Levea C, Fakih MG (2009) Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes. Anticancer Res 29: 465-468.
8. Papac RJ (1998) Spontaneous regression of cancer: possible mechanisms. In Vivo 12: 571-578.
9. Seyfried TN (2012) Cancer as Metabolic Diseases. John Wiley & Sons, Inc., Hobaken, New Jersey, USA.
10. Jose C, Bellance N, Rossignol R (2011) Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochim Biophys Acta 1807: 552-561.
11. Dang CV (2012) Links between metabolism and cancer. Genes Dev 26: 877-890.
12. Zhao Y, Butler EB, Tan M (2013) Targeting cellular metabolism to improve cancer therapeutic. Cell Death and Disease 4: e532.
13. Garg SK, Maurer H, Reed K, Selagamsetty R (2013) Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab.
14. Pan SY, DesMeules M (2009) Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence. Methods Mol Biol 472: 191-215.
15. Hursting SD, Smith SH, Lashinger LM, Harvey AE, Perkin SN (2010) Calories and carcinogenesis: Lessons learn from 30 years of caloric restriction research. Carcinogenesis 31: 82.
16. Diaz-Ruiz R, Rigoulet M, Devin A (2011) The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. Biochim Biophys Acta 1807: 568-576.
17. Dell' Antone P (2012) Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects? Med Hypotheses 79: 388-392.
18. Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, et al. (2009) Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol 27: 1082-1086.
19. Yu T, Robotham JL, Yoon Y (2006) Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 103: 2653-2658.
20. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, et al. (2008) Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 205: 2409-2417.
21. Stattin P, Björ O, Ferrari P, Lukanova A, Lenner P, et al. (2007) Prospective study of hyperglycemia and cancer risk. Diabetes Care 30: 561-567.
22. Hammarsten J, Högstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41: 2887-2895.
23. Zhang Y, Zhou J, Wang T, Cai L (2007) High level glucose increases mutagenesis in human lymphoblastoid cells. Int J Biol Sci 3: 375-379.
24. Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5: 14.
25. Nogueira V, Hay N (2013) Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res 19: 4309-4314.
26. Szatrowski TP, Nathan CF (1991) Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798.
27. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358: 1-3.
28. Vasquez-Vivar J, Kalyanaraman B, Kennedy MC (2000) Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J Biol Chem 275: 14064-14069.
29. Carew JS, Huang P (2002) Mitochondrial defects in cancer. Mol Cancer 1: 9.
30. Wallace DC, Fan W (2010) Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10: 12-31.
31. Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, et al. (2007) Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 282: 4524-4532.
32. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, et al. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7: 77-85.
33. Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen species: ffteen years later. Biochem Pharmacol 72: 1493-1505.
34. Görlach A, Bonello S (2008) The cross-talk between NF-kappaB and HIF-1: further evidence for a signifcant liaison. Biochem J 412: e17-19.
35. van Uden P, Kenneth NS, Rocha S (2008) Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412: 477-484.
36. Valle A, Oliver J, Roca P (2010) Role of uncoupling proteins in cancer. Cancers (Basel) 2: 567-591.
37. Lin CS, Klingenberg M (1982) Characteristics of the isolated purine nucleotide binding protein from brown fat mitochondria. Biochemistry 21: 2950-2956.
38. Vidal-Puig AJ, Grujic D, Zhang CY, Hagen T, Boss O, et al. (2000) Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 275: 16258-16266.
39. Andrews ZB, Horvath TL (2009) Uncoupling protein-2 regulates lifespan in mice. Am J Physiol Endocrinol Metab 296: E621-627.
40. Stefanadis C, Chrysochoou C, Markou D, Petraki K, Panagiotakos DB, et al. (2001) Increased temperature of malignant urinary bladder tumors in vivo: the application of a new method based on a catheter technique. J Clin Oncol 19: 676-681.
41. Azzu V, Jastroch M, Divakaruni AS, Brand MD (2010) The regulation and turnover of mitochondrial uncoupling proteins. Biochim Biophys Acta 1797: 785-791.
42. Yang ZJ, Chee CE, Huang S, Sinicrope FA (2011) The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10: 1533-1541.
43. Samudio I, Fiegl M, Andreeff M (2009) Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69: 2163-2166.
44. More DJ, Reust T (1997) A circulating Form of NADH oxidase Activity Responsive to the Antitumor Sulfonyl Urea N-4(methylphenylsulfonyl)-N-(4-chlorophenyl)urea LY181984 specifc to sera cancer patients. J Bioenerg Biomembr 29: 281-289.
45. Morre DJ, Byrn SR, Crane FL, Morre MD (1997) US Patent 5605810-NADH oxidase assay for neoplasia determination.
46. Houtkooper RH, Cantó C, Wanders RJ, Auwerx J (2010) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31: 194-223.
47. Lu W, Hu Y, Chen G, Chen Z, Zhang H, et al. (2012) Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol 10: e1001326.
48. Li X, Kazgan N (2011) Mammalian sirtuins and energy metabolism. Int J Biol Sci 7: 575-587.
49. Teodoro JS, Rolo AP, Palmeira CM (2013) The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? Toxicol Mech Methods 23: 297-302.
50. Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfde/glutathione couple. Free Radic Biol Med 30: 1191-1212.
51. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, et al. (2010) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 29: 5299-5310.
52. Filomeni G, Desideri E, Cardaci S, Rotilio G, Ciriolo MR (2010) Under the ROS...thiol network is the principal suspect for autophagy commitment. Autophagy 6: 999-1005.
53. Mathew R, White E (2011) Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. Cold Spring Harb Symp Quant Biol 76: 389-396.
54. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, et al. (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with market increase of glutathione synthesis. Proc Natl Acad Sci U S A 89: 3070-3074.
55. Singh S, Khan AR, Gupta AK (2012) Role of glutathione in cancer pathophysiology and therapeutic interventions. J Exp Ther Oncol 9: 303-316.
56. Nikan B (2010) Spontaneous remission of cancer: Steady and aggressive malignant growth faced with hypoxia and hypoglycemia. Med Hypotheses 75: 505-506.
57. Krebs HA, Speaks RN, Hems R (1965) Accelerations of renal gluconeogenesis by ketone bodies and fatty acids. Biochem J 94: 712-720.
58. Oleksyszyn J (2012) Hyperglycemia and Tumor Energy Metabolism. J Pharmacol Biomed Anal 1: e101.
59. Oleksyszyn J (2011) The complete control of glucose level utilizing the composition of ketogenic diet with the gluconeogenesis inhibitor, the anti-diabetic drug metformin, as a potential anti-cancer therapy. Med Hypotheses 77: 171-173.
60. Viollet B, Guigas B, Sanz Garcia N, Leclerc J, Foretz M, et al. (2012) Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) 122: 253-270.
61. Hoption Cann SA, van Netten JP, van Netten C (2003) Dr William Coley and tumour regression: a place in history or in the future. Postgrad Med J 79: 672-680.
62. Delmastro-Greenwood MM, Piganelli JD (2013) Changing the energy of an immune response. Am J Clin Exp Immunol 2: 30-54.
63. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, et al. (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109: 3812-3819.
64. Lardner A (2001) The effects of extracellular pH on immune function. J Leukoc Biol 69: 522-530.
65. Amir S, Harel M (1985) Systemic hypoglycemia following central injection of endotoxin in mice. Brain Res 339: 382-385.
66. Caton PW, Nayuni NK, Murch O, Corder R (2009) Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase. Life Sci 84: 738-744.
67. Wolfe RR, Elahi D, Spitzer JJ (1977) Glucose kinetics in dogs following a lethal dose of endotoxin. Metabolism 26: 847-850.
68. Witek-Janusek L, Filkins JP (1983) Relation of endotoxin structure to hypoglycemic and insulinlike actions. Circ Shock 11: 23-34.
69. Oguri S, Motegi K, Iwakura Y, Endo Y (2002) Primary role of interleukin-1 alpha and interleukin-1 beta in lipopolysaccharide-induced hypoglycemia in mice. Clin Diagn Lab Immunol 9: 1307-1312.